Repligen Corporation (RGEN): Price and Financial Metrics
RGEN Price/Volume Stats
| Current price | $128.30 | 52-week high | $182.52 |
| Prev. close | $126.70 | 52-week low | $102.96 |
| Day low | $127.80 | Volume | 599,466 |
| Day high | $130.68 | Avg. volume | 757,079 |
| 50-day MA | $128.18 | Dividend yield | N/A |
| 200-day MA | $143.15 | Market Cap | 7.21B |
RGEN Stock Price Chart Interactive Chart >
Repligen Corporation (RGEN) Company Bio
Repligen Corporation develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company was founded in 1981 and is based in Waltham, Massachusetts.
RGEN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RGEN Price Returns
| 1-mo | 1.12% |
| 3-mo | -17.60% |
| 6-mo | -14.01% |
| 1-year | -13.63% |
| 3-year | -24.31% |
| 5-year | 6.69% |
| YTD | -10.87% |
| 2024 | -19.94% |
| 2023 | 6.20% |
| 2022 | -36.07% |
| 2021 | 38.20% |
| 2020 | 107.17% |